Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis

BACKGROUND. The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine‐based triplet and neurokinin‐1 receptor antagonists (NK‐1RAs)‐based triplet. However, which one shows better antiemetic effect remained unclear. MATERIALS AND METHODS...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Zhang, Zhonghan, Zhang, Yaxiong, Chen, Gang, Hong, Shaodong, Yang, Yunpeng, Fang, Wenfeng, Luo, Fan, Chen, Xi, Ma, Yuxiang, Zhao, Yuanyuan, Zhan, Jianhua, Xue, Cong, Hou, Xue, Zhou, Ting, Ma, Shuxiang, Gao, Fangfang, Huang, Yan, Chen, Likun, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2018
Teme:
Symptom Management and Supportive Care
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947448/
https://ncbi.nlm.nih.gov/pubmed/29330211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0378
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki